Jamjoom Pharmaceuticals Factory Co.

4015 Healthcare Shariah
شركة مصنع جمجوم للأدوية
144.20 SAR
+0.90 (+0.63%)
Live • 12:46
Open
144.50
High
145.60
Low
143.60
Volume
0.0M
52W High
183.80
52W Low
134.00
Market Cap
10.14B SAR
P/E Ratio
21.55
Dividend Yield
5.52%
Beta
0.74

Price Chart

627 trading days
Since Jun 2023

Technical Analysis

DOWNTREND
RSI (14)
33.2
Neutral
Volatility (20D)
25.2%
Support
139.47
Resistance
142.17

Moving Averages

SMA 20
147.96
SMA 50
152.00
SMA 200
159.75
MA: Bearish RSI: Neutral

About Jamjoom Pharmaceuticals Factory Co.

Jamjoom Pharmaceuticals Factory is a prominent player in the pharmaceutical industry based in Saudi Arabia. As a manufacturer, the company's primary function is to develop, produce, and distribute a broad range of pharmaceutical products. Jamjoom Pharmaceuticals serves multiple sectors, including healthcare, hospitals, and pharmacies, delivering essential medicines that cater to various medical needs. The company's product portfolio includes both prescription medications and over-the-counter drugs, addressing therapeutic areas such as cardiovascular health, diabetes management, and ophthalmology. This diverse range of offerings underscores its commitment to enhancing healthcare and improving patient outcomes across the region. Jamjoom Pharmaceuticals Factory's role in the financial market is significant, particularly within the Middle Eastern pharmaceutical sector. It contributes to the local economy by supporting healthcare infrastructure and advancing medical care standards. The company's involvement in research and development further solidifies its position as a key player, continuously striving to bring innovative solutions to the healthcare industry. By focusing on quality and accessibility, Jamjoom Pharmaceuticals is pivotal in meeting the growing medical demands of the population.

Sector Healthcare
Employees N/A
CEO
Website Visit

Performance

1 Day +0.63%
5 Days +0.28%
1 Month -3.76%
3 Months -8.49%
1 Year -8.26%
52-Week Range
134.00 183.80
20.5% of range

Key Statistics

As of 2025-12-21
Market Cap 10.14B SAR
P/E Ratio 21.55
Forward P/E 20.22
EPS (TTM) 6.38 SAR
Dividend Yield 5.52%
Beta 0.74
Avg Volume 33,439

Latest News

No recent news for 4015